Medical Director

East Midlands Region
£77,913 - £105,042
12 Feb 2019
10 Mar 2019
Career Level
Contract Type
Full Time

See your future with us 
Medical Director
for East Midlands and East of England NHS Genomics Laboratory Hub

The East Midlands and East of England NHS Genomic Laboratory Hub (EMEE GLH) is one of seven Genomic Hubs recently established to provide the new National Genomic Medicine Service for NHS England. Led by Cambridge University Hospitals NHS Foundation Trust and working with Nottingham University Hospital and University Hospital Leicester, the EMEE GLH will offer a high quality service to deliver the tests listed in the National Genomic Test Directory, for a population of 10million.This includes diagnostic tests for inherited disorders and for cancer, disease monitoring and predictive tests, and in future will include pharmacogenomic testing. The Laboratory in Cambridge is based on the Cambridge Biomedical Campus where world leading academic and industry scientists are co-located alongside the renowned teaching hospitals of the University of Cambridge, providing an optimum environment to translate research findings into clinical practice. 

We are now seeking a Medical Director for the GLH, who will provide corporate, strategic, and clinical leadership and direction to the EMEE GLH. This is an exciting opportunity to contribute at high level to the establishment of the new Genomic Medicine Service for the NHS. The Medical Director will work closely with the GLH Scientific and Operational Directors, NHSE Genomics Unit, Trust CEO’s, Clinicians and patients throughout the region, to provide a high quality Genomic Medicine Service. The postholder will be supported by Clinical leads in the GLH, with specialisation in rare disease, cancer genomics, pathology,  and haematological malignancy. The successful applicant will be a senior medical consultant with nationally/internationally recognised expertise in genomics and/or in one of these specialties, with extensive experience of clinically interpreting and advising on the clinical actionability of complex genomic data up to the level of whole genome sequencing. The GLH Medical Director may additionally be considered for one of the specialty roles, following appropriate appointment.

5 PAs are allocated to this post, and the remaining 5 PAs are for clinical work. We would anticipate that this would be a permanent consultant appointment in the relevant specialty, however the MD post is currently offered for a term of 5+2 years. 

For an informal discussion about this post, please contact:

Closing date: 10 March 2019.

To apply, please click the apply button quoting reference 180-MD-2913.

Addenbrooke’s and the Rosie Hospitals Innovation and Excellence in Health and Care